CSL Limited

$103.29
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.

-$1.66 (-1.58%) Today
$0.00 (0.00%) As of 4:33 PM EDT after-hours

Why Robinhood?

You can buy or sell CSL Limited and other stocks, options, ETFs, and crypto commission-free!

About CSLLY

Csl Ltd SPONSORED ADR (Australia), also called CSL Limited, is a biopharmaceutical company, which engages in the manufacture, marketing, and distribution of biopharmaceutical and allied products. It operates through the CSL Behring and Seqirus segments. Read More The CSL Behring segment provides plasma therapies and conducts early stage research on plasma and non plasma therapies. The Seqirus segment involves in the production of non-plasma biotherapeutic products and develops influenza related products. The company was founded on November 2, 1961 and is headquartered in Parkville, Australia. CSLLY is listed on the Pink Current market tier. OTC market data is provided by OTC Markets Group, Inc (otcmarkets.com).

Employees
27,000
Headquarters
Parkville, Victoria (VIC)
Founded
1961
Market Cap
93.98B
Price-Earnings Ratio
44.62
Dividend Yield
0.91
Average Volume
39.18K
High Today
$106.20
Low Today
$102.75
Open Price
$106.20
Volume
32.87K
52 Week High
$114.40
52 Week Low
$75.19

Collections

CSLLY News

ReutersSep 16

Philippines says engaging Western pharma firms, despite Duterte anger

MANILA (Reuters) - The Philippines continues to negotiate supply deals with a wide range of COVID-19 vaccine makers, its health ministry said on Wednesday, desp
ReutersSep 15

Australia's CSL to manufacture two COVID-19 vaccines, shares up

FILE PHOTO: Small bottles labeled with a "Vaccine COVID-19" sticker and a medical syringe are seen in this illustration taken taken April 10, 2020. REUTERS/Dado
ReutersSep 15

Australia shares dip as banks drag; eyes on U.S. Fed meeting

* “Big Four” banks drop up to 1.9% * Gold stocks jump to their highest in nearly a month * Poll shows NZ set to officially enter recession (Updates to close)

You May Also Like

More CSLLY News

ReutersSep 14

Philippines to prioritise coronavirus vaccine supply from Russia or China

MANILA, Sept 15 (Reuters) - Philippine President Rodrigo Duterte vowed on Monday to prioritise buying COVID-19 vaccine to be made available by Russia or China,
Robinhood Snacks newsletters and podcasts reflect the opinions of only the authors who are associated persons of Robinhood Financial LLC and do not reflect the views of Robinhood Markets, Inc. or any of its subsidiaries or affiliates. They are meant for informational purposes only, are not intended to serve as a recommendation to buy or sell any security in a self-directed Robinhood account or any other account, and are not an offer or sale of a security. They are also not research reports and are not intended to serve as the basis for any investment decision. Any third-party information provided therein does not reflect the views of Robinhood Markets, Inc., Robinhood Financial LLC, or any of their subsidiaries or affiliates. All investments involve risk and the past performance of a security or financial product does not guarantee future results or returns. Keep in mind that while diversification may help spread risk, it does not assure a profit or protect against loss. There is always the potential of losing money when you invest in securities or other financial products. Investors should consider their investment objectives and risks carefully before investing. The price of a given security may increase or decrease based on market conditions and customers may lose money, including their original investment. Robinhood Financial LLC, member FINRA/SIPC.

All investments involve risk and the past performance of a security, or financial product does not guarantee future results or returns. Securities offered through Robinhood Financial LLC, member FINRA/SIPC. To learn more about the information provided on this page, please see our Web Disclosures.